The Bone Scan in Metastatic Disease

  • I. Fogelman
  • J. H. McKillop

Abstract

In recent years there have been dramatic advances in all the imaging specialities, with growth of the use of ultrasound and computed tomography (CT) scanning and the introduction of magnetic resonance imaging (MRI). An integrated imaging approach to a specific problem is required for optimal results and the use of these newer modalities is discussed elsewhere in this book. Nevertheless, despite these changes the radionuclide bone scan remains unchallenged in its role of investigating skeletal pathology, because of its exquisite sensitivity for lesion detection and its ability rapidly to evaluate the whole skeleton. In contrast to routine radiology, sites such as ribs, sternum and scapula are clearly seen. The early experience of bone scanning was almost exclusively in patients with known malignancy and, while the role of bone scanning has now expanded to many benign situations, the identification of metastases still remains the most important indication for a bone scan. In this review we shall attempt to define the role of bone scanning in the detection and monitoring of skeletal metastases.

Keywords

Oncol Radionuclide Flare Hydroxyapatite Gallium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander JL, Gillespie PJ, Edelstyn GA (1982) Serial bone scanning using technetium 99m diphosphonate in patients undergoing cyclical combination chemotherapy for advanced breast cancer. Clin Nucl Med 7:397–402CrossRefGoogle Scholar
  2. Antoniades J, Croll MN, Walner RJ, Brady LW, McKhann CB (1976) Bone scanning in carcinoma of the colon and rectum. Dis Colon Rectum 19:139–143PubMedCrossRefGoogle Scholar
  3. Aranha GV, Simmons RL, Gunnarsson A, Grage TB (1979) The value of preoperative screening procedures in stage I and II malignant melanoma. J Surg Oncol 11:1–6PubMedCrossRefGoogle Scholar
  4. Au FC, Maier WP, Malmud LS, Goldman LI, Clark WH (1984) Preoperative nuclear scans in patients with melanoma. Cancer 53:2095–2097PubMedCrossRefGoogle Scholar
  5. Babaian RJ, Johnson DE, Llamas L, Ayala AG (1980) Metastases from transitional cell carcinoma of urinary bladder. Urology 16:142–144PubMedCrossRefGoogle Scholar
  6. Baker RR (1978) Preoperative assessment of the patient with breast cancer. Surg Clin North Am 64:1039–1050.Google Scholar
  7. Bassan JS, Glaser MG (1982) Bony metastases in carcinoma of the uterine cervix. Clin Radiol 33:623–625PubMedCrossRefGoogle Scholar
  8. Beals RK, Lawton GD, Swell WE (1971) Prophylactic internal fixation of the femur in metastatic breast cancer. Cancer 28:1350–1354PubMedCrossRefGoogle Scholar
  9. Belson TP, Lehman RH, Chobanian DL, Malin TC (1980) Bone and liver scans in patients with head and neck carcinoma. Laryngoscope 90:1291–1296PubMedCrossRefGoogle Scholar
  10. Berger GL, Sadlowski RW, Sharpe JR, Finney RP (1981) Lack of value of routine preoperative bone and liver scans in cystectomy candidates. J Urol 125:637–639PubMedGoogle Scholar
  11. Biersack HJ, Wegner G, Distelmaier W, Krause U (1980) Ossare Metastasierung des Prostatakerzi-noms in Abhangigkeit von Tumorgrosse und Geschwulstdifferenzienung. Nuklearmedizin 19:29–32PubMedGoogle Scholar
  12. Bishop HM, Blamey RW, Morris AH, Rose DH, Preston B, Lane J, Doyle PJ (1979) Bone scanning: its lack of value in the follow-up of patients with breast cancer. Br J Surg 66:752–754PubMedCrossRefGoogle Scholar
  13. Bitran LD, Beukerman C, Pinsky S (1981) Sequential scintigraphic staging of small cell carcinoma. Cancer 47:1971–1975PubMedCrossRefGoogle Scholar
  14. Bourgeois P, Gassavelis C, Malarme M, Feremans W, Fruhling J (1989) Bone marrow scintigraphy in breast cancer. Nucl Med Commun 10:389–400PubMedCrossRefGoogle Scholar
  15. Brismar J, Gustafson T (1988) Bone scintigraphy in staging of bladder carcinoma. Acta Radiologica 29:251–252PubMedCrossRefGoogle Scholar
  16. British Breast Group (1978) Bone scanning in breast cancer. Br Med J ii: 180–181Google Scholar
  17. Brown ML (1983) Significance of the solitary lesion in pediatric bone scanning. J Nucl Med 24:114–115PubMedGoogle Scholar
  18. Ciatto S, Pacini P, Bravetti P, Cataliotta L, Cardona G, Crescioli R, Pupi A (1985) Staging breast cancer -screening for occult metastases. Tumori 71:339–344PubMedGoogle Scholar
  19. Citrin DL, Bessent RG, Greig WR (1977) A comparison of the sensitivity and accuracy of the Tc99m phosphate bone scan and skeletal radiograph in the diagnosis of bone metastases. Clin Radiol 28:107–117PubMedCrossRefGoogle Scholar
  20. Citrin DL, Furnival CM, Bessent RG, Greig WR, Bell G, Blumgart LH (1976) Radioactive technetium phosphate bone scanning in preoperative assessment and follow-up study of patients with primary carcinoma of the breast. Surg Gynecol Obstet 143:360–364PubMedGoogle Scholar
  21. Chaudary MA, Maisey MN, Shaw P, Rubens RD, Hayward JL (1983) Sequential bone scanning and chest radiographs in the postoperative management of early breast cancer. Br J Surg 70:517–518PubMedCrossRefGoogle Scholar
  22. Clyne CAC, Frank JW, Jenkins JD, Smart CJ (1983) The place of 99mTc-polyphosphonate bone scan in renal carcinoma. Br J Urol 55:174–175PubMedCrossRefGoogle Scholar
  23. Coleman, RE, Habibollahi R, Rubens RD, Fogelman I (1986) Bone scintigraphy in early breast cancer: The relevance of tumour characteristics in identifying patients for serial scanning. Nucl Med Commun 7:292Google Scholar
  24. Coleman, RE, Rubens, RD (1985) Bone metastases and breast cancer. Cancer Treat Rev 12:251–270PubMedCrossRefGoogle Scholar
  25. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55:61–66PubMedCrossRefGoogle Scholar
  26. Coleman RE, Rubens RD, Fogelman I (1988a) Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 29:1345–1349Google Scholar
  27. Coleman RE, Rubens RD, Fogelman I (1988b) A reappraisal of the baseline bone scan in breast cancer. J Nucl Med 29:1045–1049PubMedGoogle Scholar
  28. Coleman RE, Rubens RD, Meier C, Fogelman I (1987) A clinical comparison of two bone scanning agents in breast cancer (Abstract). Nucl Med Commun 8:245–246Google Scholar
  29. Constable AR, Cranage RW (1981) Recognition of the superscan in prostatic bone scintigraphy. Br J Radiol 54:122–125PubMedCrossRefGoogle Scholar
  30. Corcoran RJ, Thrall JH, Kyle RW (1976) Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 121:663–667PubMedGoogle Scholar
  31. Corrie D, Timmons JH, Bauman JH, Thompson IM (1988) Efficacy of follow-up scans in carcinoma of prostate. Cancer 61:195–202CrossRefGoogle Scholar
  32. Daubenton JD, Fisher RM, Karabus CD, Mann MD (1987) The relationship between prognosis and scintigraphic evidence of bone metastases in neuroblastoma. Cancer 59:1586–1589PubMedCrossRefGoogle Scholar
  33. Davey P, Merrick MV, Duncan W, Padpath AT (1985) Bladder cancer: the value of routine bone scintigraphy. Clin Radiol 36:77–79PubMedCrossRefGoogle Scholar
  34. Davies CJ, Griffiths PA, Preston BJ, Morris AH, Elston CW, Blamey RW(1977) Staging breast cancer. Role of scanning. Br Med J ii:603– 605CrossRefGoogle Scholar
  35. DeGroot LJ, Reilly M (1984) Use of isotope bone scans and skeletal survey x-rays in the follow-up of patients with thyroid carcinoma. J Endocrinol Invest 7:175–179Google Scholar
  36. Donato AT, Ammerman EG, Sullesta O (1979) Bone scanning in the evaluation of the patients with lung cancer. Ann Thorac Surg 27:300–304PubMedCrossRefGoogle Scholar
  37. Drelichman A, Decker A, Al-Sarraf M, Vaitkevicius VK, Muz J (1984) Computerised bone scan. A potentially useful technique to measure response in prostatic carcinoma. Cancer 53:1061–1065Google Scholar
  38. Du Toit JP, Grove DV (1987) Radio-isotope bone scanning for the detection of occult bony metastases in invasive cervical carcinoma. Gynecol Oncol 28:215–219PubMedCrossRefGoogle Scholar
  39. Edelstyn GA, Gillespie PJ, Grebell FS (1967) The radiological demonstration of osseus metastases: experimental observations. Clin Radiol 18:158–162PubMedCrossRefGoogle Scholar
  40. El Domeiri AA, Shroff S (1976) Role of preoperative bone scan in carcinoma of the breast. Surg Gynecol Obstet 142:722–724PubMedGoogle Scholar
  41. Fogelman I (1982) Diphosphonate bone scanning agents -current concepts. Eur J Nucl Med 7:506–509PubMedGoogle Scholar
  42. Fogelman I (1987) Tc99m Bone scanning agents. In: Fogelman I (ed) Bone scanning in clinical practice. Springer-Verlag, London, pp 31–40CrossRefGoogle Scholar
  43. Fogelman I, Coleman R (1988) The bone scan in breast cancer. In: Freeman L, Weissman H (eds) Nuclear medicine annual. Raven Press, New York, pp 1–38Google Scholar
  44. Fogelman I, McKillop JH, Greig WR, Boyle IT (1977) Absent kidney sign associated with symmetrical and uniformly increased uptake of tracer by the skeleton. Eur J Nucl Med 2:257–260PubMedCrossRefGoogle Scholar
  45. Fon GT, Wong WS, Gold RH, Kaiser LR (1981) Skeletal metastases of melanoma. AJR 137:103–108PubMedGoogle Scholar
  46. Francis MD, Fogelman I (1987) Tc99m diphosphonate uptake mechanism on bone. In: Fogelman I (ed) Bone scanning in clinical practice Springer Verlag, Berlin Heidelberg New York, pp 7–17CrossRefGoogle Scholar
  47. Freeman MH, Tonkin AK (1976) Manifestations of hypertrophic pulmonary osteoarthropathy in patients with carcinoma of the lung. Demonstration by 99mTc pyrophosphate bone scans. Radiology 120:363–365Google Scholar
  48. Furnival CM, Blumgart LH, Citrin DL, McKillop JH, Fogelman I, Greig WR (1980) Serial scintiscanning in breast cancer: Indications and prognostic value. Clin Oncol 6:25–32.PubMedGoogle Scholar
  49. Galasko CSB (1975) The significance of occult skeletal metastases, detected by scintigraphy, in patients with otherwise early breast cancer. Br J Surg 56:757–764CrossRefGoogle Scholar
  50. George MJ (1988) Natural history of localised prostatic cancer managed by conservative therapy alone. Lancet 1:494–497PubMedCrossRefGoogle Scholar
  51. Gerber FH, Goodreau JJ, Kirchner PT, Fonty WJ (1977) Efficacy of preoperative and postoperative bone scanning in the management of breast carcinoma. N Engl J Med 297:300–303PubMedCrossRefGoogle Scholar
  52. Gilbert HB, Kagan AR (1976) Metastases: incidence, detection and evaluation. In: Weiss L (ed) Fundamental aspects of metastases. Elsevier, Amsterdam pp 385–405Google Scholar
  53. Gillespie PJ, Alexander JL, Edelstyn GA (1975) Changes in 87mSr concentrations in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer. J Nucl Med 16:191–193PubMedGoogle Scholar
  54. Goris ML, Bretille J (1985) Skeletal scintigraphy for the diagnosis of malignant metastatic disease to the bones. Radiother Oncol 3:319–329PubMedCrossRefGoogle Scholar
  55. Gravenstein S, Peltx MA, Poreis W (1979) How ominous is an abnormal scan in bronchogenic carcinoma? JAMA 241:2523–2524PubMedCrossRefGoogle Scholar
  56. Gray HW (1987) Soft tissue uptake of bone agents. In: Fogelman I (ed) Bone scanning in clinical practice. Springer-Verlag, Berlin Heidelberg New York, pp 211–235CrossRefGoogle Scholar
  57. Greenberg EJ, Chu FCH, Dwyer AJ, Ziminski EM, Dimisch AB Laughlin JS (1972) Effects of radiation therapy on bone lesions as measured by 47Ca and 85Sr local kinetics. J Nucl Med 13:747–751Google Scholar
  58. Harbert JC, Rocha L, Smith FO, Delgado G (1982) The efficacy of radionuclide bone scans in the evaluation of gynecological cancers. Cancer 49:1040–1042PubMedCrossRefGoogle Scholar
  59. Hatfield DR, DeLand FH, Maruyama Y (1976) Skeletal metastases in pancreatic cancer: a study by isotope bone scanning. Oncology 33:44–47PubMedCrossRefGoogle Scholar
  60. Hayward JL, Carbone PP, Heuson JC, Kumoaka S, Sgaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13:89–94Google Scholar
  61. Hayward SJ, Mclvor J, Burdge AH, Jewkes RF, Williams G (1987) Staging of prostatic cancer with radionuclide bone scintigraphy and lymphography. Br J Radiol 60:79–81PubMedCrossRefGoogle Scholar
  62. Hetherington JW, Siddall JK, Cooper EH (1988) Contribution of bone scintigraphy, prostatic acid phosphatase and prostatic specific antigen to the monitoring of prostatic cancer. Eur Urol 14:1–5PubMedGoogle Scholar
  63. Hoefnagel CA, Delprat CC, Marcuse HR, de Viilder JJM (1986) Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 27:1854–1857PubMedGoogle Scholar
  64. Hooper RG, Beechler CR, Johnson MC (1978) Radioisotope scanning in the initial staging of bronchogenic carcinoma. Am Rev Resp Dis 118:279–286PubMedGoogle Scholar
  65. Howman-Giles RB, Gilday DL, Ash JM (1979) Radionuclide skeletal survey in neuroblastoma. Radiology 131:497–502PubMedGoogle Scholar
  66. Huben RP, Schellhammer PF (1982) The role of routine follow up bone scans after definitive therapy of localised prostatic cancer. J Urol 128:510–512PubMedGoogle Scholar
  67. Johnson DG, Coleman RE, McCook TA, Dale JK, Wells SA (1984) Bone and liver images in medullary carcinoma of the thyroid. J Nucl Med 25:419–422PubMedGoogle Scholar
  68. Joo KG, Parthasarathy KL, Bakshi SP, Rosner D (1979) Bone scintigrams: Their clinical usefulness in patients with breast carcinoma. Oncology 36:94–98PubMedCrossRefGoogle Scholar
  69. Kamath CRV, Maruyama Y, De Land FH, van Nagell JR (1982) Value of bone scanning in detecting occult skeletal metastases from adenocarcinoma of the endometrium. Diagn Gynecol Obstet 4:155–158PubMedGoogle Scholar
  70. Kamath CRV, Maruyama Y, De Land FH, van Nagell JR (1983) Role of bone scanning for evaluation of carcinoma of the cervix. Gynecol Oncol 15:171–185PubMedCrossRefGoogle Scholar
  71. Katz RD, Alderson PO, Rosenhein NB, Bowerman JW, Wagner HN Jr (1979) Utility of bone scanning in detecting occult metastases from cervical carcinoma. Radiology 133:469–472PubMedGoogle Scholar
  72. Kelly RJ, Cason RJ, Ferrie CB (1979) Efficacy of radionuclide scanning in patients with lung cancer. JAMA 242:2855–2857PubMedCrossRefGoogle Scholar
  73. Khansur T, Haick A, Patel B, Balducci L, Vance R, Thigpen T (1987) Evaluation of bone scan as a screening work-up in primary and loco-regional recurrence of breast cancer. Am J Clin Oncol 10:167–170PubMedCrossRefGoogle Scholar
  74. Kies MS, Baker AW, Kennedy PS (1978) Radionuclide scans in staging of carcinoma of the lung. Surg Gynecol Obstet 147:175–176PubMedGoogle Scholar
  75. Kim EE, Bledin AG, Gutierrez C, Haynie TP (1983) Comparison of radionuclide images and radiographs for skeletal metastases from renal cell carcinoma. Oncology 40:284–286PubMedCrossRefGoogle Scholar
  76. Kishi K, Horita T, Matsumoto K, Kakizoe T, Murase T, Fujita J (1981) Carcinoma of bladder: A clinical and pathological analysis of 87 autopsy cases. Urology 125:36–39Google Scholar
  77. Kober B, Hermann HJ, Wetzel E (1979) “Cold lesions” in bone scintigraphy. Fortschr Rotgenstr 131:545–551CrossRefGoogle Scholar
  78. Koizumi K, Tonami N, Hisada K (1981) Diffusely increased Tc-99m MDP uptake in both kidneys. Clin Nucl Med 6:362–365PubMedCrossRefGoogle Scholar
  79. Komaki R, Cox, JD, Eisert RD (1977) Irradiation of bronchial carcinoma. II. Pattern of spread and potential for prophylactic irradiation. Int J Radiat Oncol Biol Phys 2:441–446PubMedCrossRefGoogle Scholar
  80. Komaki R, Donegan W, Manoli R, Teh EL (1979) Prognostic value of pretreatment bone scans in breast cancer. AJR 132:877–881PubMedGoogle Scholar
  81. Kunkler IH, Merrick MV, Rodger A (1985) Bone scintigraphy in breast cancer: a nine year follow-up. Clin Radiol 36:279–282PubMedCrossRefGoogle Scholar
  82. Levenson RM, Sauerbrunn BJL, Bates HR, Newman RD, Eddy JL, Ihde DC (1983) Comparative value of bone scintigraphy and radiography in monitoring tumour response in systemically treated prostatic cancer. Radiology 146:513–518PubMedGoogle Scholar
  83. Levenson RM, Saubrunn BJL, Ihde DE et al. (1981) Small cell cancer: radionuclide bone scans for assessment of tumour extent and response. AJR 137:31–35PubMedGoogle Scholar
  84. Lindner A, Dekernion JB (1982) Cost effectiveness of pre cystectomy radioisotopic scans. J Urol 128:1181–1182PubMedGoogle Scholar
  85. Lindholm A, Lundell L, Martenson B, Thulin A (1979) Skeletal scintigraphy in the initial assessment of women with breast cancer. Acta Chir Scand 145:513–518Google Scholar
  86. Lopez-Majano V, Sobti P (1984) Early diagnosis of pulmonary osteoarthropathy in neoplastic disease. J Nucl Med Allied Sci 28:69–76PubMedGoogle Scholar
  87. Lund F, Smith PH, Suciu S (1984) Do bone scans predict prognosis in prostatic cancer? Br J Urol 56:58–63PubMedCrossRefGoogle Scholar
  88. Marsoni S, Hurson S, Eisenberg M (1985) Chemotherapy of bone metastases. In: Garratini S (ed) Bone resorption, metastasis and diphosphonates. Raven Press, New York, pp 181–194Google Scholar
  89. McGregor B, Tulloh AGS, Quinlan MF, Lovegrove F (1978) The role of bone scanning in the assessment of prostatic carcinoma. Br J Urol 50:178–181PubMedCrossRefGoogle Scholar
  90. McNeil BJ (1984) Value of bone scanning in malignant disease. Semin Nucl Med 14:277–286PubMedCrossRefGoogle Scholar
  91. McNeil BJ, Pace PD, Gray EB, Adelstein SJ, Wilson RE (1978) Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 147:745–748PubMedGoogle Scholar
  92. McNeil BJ, Polak JF (1981) An update on the rationale for the use of bone scans in selected metastatic and primary bone tumours. In: Pauwels EKJ, Schutte HE, Taconis WK (eds) Bone scintigraphy. Leiden University Press, Leiden, pp 187–208CrossRefGoogle Scholar
  93. Merrick MV (1987a) The normal bone scan. In: Fogelman I (ed) Bone scanning in clinical practice. Springer-Verlag, Berlin Heidelberg New York, pp 19–20CrossRefGoogle Scholar
  94. Merrick MV (1987b) Bone scintigraphy in testicular tumours. Br J Urol 60:167–169PubMedCrossRefGoogle Scholar
  95. Merrick MV (1989) Bone scintigraphy -an update. Clin Radiol 40:231–232PubMedCrossRefGoogle Scholar
  96. Merrick MV, Ding CL, Chisholm GD, Elton RD (1985) Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. Br J Urol 57:715–720PubMedCrossRefGoogle Scholar
  97. Merrick MV, Merrick JM (1986) Bone scintigraphy in lung cancer: a reappraisal. Br J Radiol 59:1185–1194PubMedCrossRefGoogle Scholar
  98. Mettler FA, Christie JH, Garcia JF, Baldwin MH, Wicks JD, Barstow SA (1981) Radionuclide liver and bone scanning in the evaluation of patients with endometrial carcinoma. Radiology 141:777–780PubMedGoogle Scholar
  99. Moneypenny IJ, Grieve RJ, Howell A, Morrison JM (1984) The value of serial bone scanning in operable breast cancer. Br J Surg 71:466–468CrossRefGoogle Scholar
  100. Muss HB, Richards F, Barnes PL, Willand VV, Cowan R (1979) Radionuclide scanning in patients with advanced malignant melanoma. Clin Nucl Med 4:516–518PubMedGoogle Scholar
  101. Narayam F, Lillian D, Hellstrom W, Hedgcock M, Jajodian PB, Tanagho EA (1988) The benefits of combining early radionuclide renal scintigraphy with routine bone scans in patients with prostatic cancer. J Urol 140:1448–1451Google Scholar
  102. Nomura Y, Kondo H, Yamagata J et al. (1978) Evaluation of liver and bone scanning in patients with early breast cancer, based on results obtained from more advanced patients. Eur J Cancer 14:1129–1136PubMedGoogle Scholar
  103. Nordman E, Marjamaki H, Tannila O (1977) The reliability of Tc99m pyrophosphate scintigraphy in the diagnosis of bony metastases. Ann Clin Res 9:31–34PubMedGoogle Scholar
  104. Donoghue EP, Constable AR, Sherwood T, Stevenson JJ, Chisholm GD (1978) Bone scanning and plasma phosphatases in carcinoma of the prostate. Br J Urol 50:172–177CrossRefGoogle Scholar
  105. Operchal JA, Bowden RD, Grove RB (1976) Efficacy of radionuclide procedures in the staging of bronchogenic carcinoma. J Nucl Med 17:530 (abstract).Google Scholar
  106. Padmanabhan N, Howell A, Rubens RD (1986) Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet 11:411–414CrossRefGoogle Scholar
  107. Parsarathy KL, Lansberg R, Bakshi SP, Donoghue G, Merrin C (1978) Detection of bone metastases in urological malignancies utilising 99mTc-labelled phosphate compound. Urology 11:99–102CrossRefGoogle Scholar
  108. Paulson DF and the Uro-Oncology Research Group (1979) The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. J Urol 121:300–302Google Scholar
  109. Pauwels EKJ, Heslinga JM, Zwaveling A (1982) Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer. Clin Oncol 8:25–32PubMedGoogle Scholar
  110. Perez DJ, Powles TJ, Milan J, Gazet JC, Ford HT, McCready VR, Macdonald JS, Coombs RC (1983) Detection of breast carcinoma metastases in bone: Relative merits of x-rays and skeletal scintigraphy. Lancet ii:613– 616Google Scholar
  111. Podarsky AER, Stark DD, Hattner RS, Goodling GA, Moss AA (1983). Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumour localisation of 99mTc-MDP. AJR 141:469–472Google Scholar
  112. Pollen JJ, Gerber K, Ashburn WL, Schmidt JD (1981) Nuclear bone imaging in metastatic cancer of the prostate. Cancer 47:1585–1594CrossRefGoogle Scholar
  113. Ouinn DL, Ostrow LB, Porter DK, Shelton DR, Jackson DE (1986) Staging of non small cell bronchogenic carcinoma. Relationship of clinical evaluation to organ scans. Chest 89:270–275Google Scholar
  114. Ralston S, Fogelman I, Gardner MD, Boyle IT (1982) Hypercalcaemia and metastatic bone disease: is there a causal link? Lancet ii:903–905Google Scholar
  115. Ramsdell JW, Peters RM, Taylor AT, Alazrak NP, Tisi GM (1977) Multiorgan scans for staging of lung cancer: correlation with clinical evaluation. J Thorac Cardiovasc Surg 73:653–659PubMedGoogle Scholar
  116. Rappaport AH, Hoffer PB, Genant HK (1978) Unifocal bone findings by scintigraphy. Clinical significance in patients with known primary cancer. West Med 129:188–192Google Scholar
  117. Reddy PS, Merrick MV (1983) Skeletal scintigraphy in carcinoma of the kidney. Br J Urol 55:171–173PubMedCrossRefGoogle Scholar
  118. Rosen PR, Murphy KG (1984) Bone scintigraphy in the initial staging of patients with renal cell carcinoma. J Nucl Med 25:289–291PubMedGoogle Scholar
  119. Rosenthall L, Stern J, Arzoumanian A (1982) A clinical comparison of MDP and DMAD. Clin Nucl Med 7:403–406PubMedCrossRefGoogle Scholar
  120. Rossleigh MA, Lovegrove FTA, Reynolds PM et al. (1984) The assessment of response to therapy of bone metastases in breast cancer. Aust NZ J Med 14:19–22CrossRefGoogle Scholar
  121. Roth JA, Eilber FR, Bennett LR, Morton DL (1975) Radionuclide photoscanning. Usefulness in preoperative evaluation of melanoma. Arch Surg 110:1211–1212PubMedCrossRefGoogle Scholar
  122. Shafer RB, Reinke DB (1977) Contribution of the bone scan, serum acid and alkaline phosphatase and radiographic bone survey to the management of newly diagnosed carcinoma of the prostate. Clin Nucl Med 2:200–203CrossRefGoogle Scholar
  123. Shearer RJ, Constable AR, Girling M, Hendry WF, Fergusson JD (1974) Radiographic bone scintigraphy with the gamma camera in the investigation of prostatic cancer. Br Med J ii:362–365CrossRefGoogle Scholar
  124. Shih WJ, Purcell M, Domstad PA (1986) Evolving scintigraphic pattern of skeletal metastases from prostatic carcinoma. J Nucl Med 27:1786–1788PubMedGoogle Scholar
  125. Sklaroff RB, Sklaroff DM (1976) Bone metastases from breast cancer at the time of radical mastectomy. Cancer 38:107–111PubMedCrossRefGoogle Scholar
  126. Smith FW, Gilday DL, Ash JM, Reid RH (1980) Primary neuroblastoma uptake of 99m-technetium methylene diphosphonate. Radiology 137:501–504PubMedGoogle Scholar
  127. Smith ML, Martin W, McKillop JH, Fogelman I (1984) Improved lesion detection with dimethyl-amino-diphosphonate: A report of two cases. Eur J Nucl Med 9:519–520PubMedCrossRefGoogle Scholar
  128. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd BN, Soloway S, Moinuddin M (1988) Stratification of patients with metastatic prostatic cancer based on extent of disease on initial bone scan. Cancer 61:195–202PubMedCrossRefGoogle Scholar
  129. Spencer GR, Khan M, Bird C, Seymour R, Brown TR, Collins CD (1981) Is bone scanning of value in patients with breast cancer? Acta Chir Scand 147:247–248PubMedGoogle Scholar
  130. Sundkvist CMG, Ahlgren L, Lilja B, Mattson S, Abrahamson PA, Wadstrom LB (1988) Repeated quantitative bone scintigraphy in patients with prostatic carcinoma treated with orchiectomy. Eur J Nucl Med 14:203–206PubMedCrossRefGoogle Scholar
  131. Sven NR, Karstens JH, Gloeckner W, Steinstrasser A, Schwarz A, Ammon J, Buell U (1989) Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet i:299– 301Google Scholar
  132. Terry DW, Isitman AI, Holmes RA (1975) Radionuclide bone images in hypertrophic pulmonary osteoarthropathy. AJR 124:571–576Google Scholar
  133. Thomas JH, Panoussopoulus D, Liesmann GE, Jewell WR, Preston DF (1979) Scintiscans in the evaluation of patients with malignant melanoma. Surg Gynecol Obstet 149:574–576PubMedGoogle Scholar
  134. Thomsen HS, Rasmussen D, Munck O, Lund JO, Gerhard-Nielsen V, Terkildsen T, Domber-nowsky P, Andersen KW (1987). Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy. Eur J Cancer Clin Oncol 23:779–781CrossRefGoogle Scholar
  135. Turner P, Haggith JW (1981) Preoperative radionuclide scanning in bronchogenic carcinoma. Br J Dis Chest 75:291–294PubMedCrossRefGoogle Scholar
  136. Vest SA (1954) Prostatic malignancy. Clin Symp 6:93–103Google Scholar
  137. Vider M, Maruyama Y, Narvaez R (1977) Significance of the vertebral venous (Batson’s) plexus in metastatic spread in colorectal cancer. Cancer 40:67–71PubMedCrossRefGoogle Scholar
  138. Wahner HW, Kyle RA, Beabout JW (1980) Scintigraphic evaluation of the skeleton in multiple myeloma. Mayo Clin Proc 55:739–746PubMedGoogle Scholar
  139. Waxman AD, Siensen JK, Levine AM (1981) Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy. J Nucl Med 22:232–236PubMedGoogle Scholar
  140. Wickerham L, Fisher B, Cronin W, members of the NSABP Committee for treatment failure. (1984) The efficacy of bone scanning in the follow-up of patients with operable breast cancer. Breast Cancer Res Treat 4:303–307PubMedCrossRefGoogle Scholar
  141. Wilkinson MJS, Howell A, Harris M, Adam NM, Lupton E, Johnson RJ, Seilwood RA (1985) Retroperitoneal tumour infiltration detected by bone scanning in patients with infiltrating lobular carcinoma of the breast. Br J Surg 72:626–628PubMedCrossRefGoogle Scholar
  142. Wolfe JA, Rowe LD, Lowry LD (1979) Value of radionuclide scanning in the staging of head and neck carcinoma. Ann Otol Rhinol Laryngol 88:832–836PubMedGoogle Scholar
  143. Wolfenden JM, Pitt MJ, Durie BGW, Moon TE (1980) Comparison of bone scintigraphy and radiology in multiple myeloma. Radiology 134:723–728Google Scholar
  144. Yeates MG, Tan PKS, Broadfoot E, Green D, Morris JG (1972) Bone scanning with technetium polyphosphate. Preliminary results. Australas Radiol 16:393–400CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1991

Authors and Affiliations

  • I. Fogelman
  • J. H. McKillop

There are no affiliations available

Personalised recommendations